Amphetamine use for attention deficit hyperactive disorder during breastfeeding and children's neurodevelopmental outcomes: A pilot study

Nofar Benassayag Kaduri; Ariela Hazan; Tal De-Haan; Elkana Kohn; Matitiahu Berkovitch; Maya Berlin

doi:10.1016/j.psychres.2024.116047

Amphetamine use for attention deficit hyperactive disorder during breastfeeding and children's neurodevelopmental outcomes: A pilot study

Nofar Benassayag Kaduri^*, Ariela Hazan, Tal De-Haan, Elkana Kohn, Matitiahu Berkovitch, Maya Berlin

^*Corresponding author for this work

Clinical Departments

Tel Aviv University

Research output: Contribution to journal › Article › peer-review

Abstract

Attention deficit hyperactive disorder (ADHD) medication use rises among women of childbearing age and during pregnancy. Little is known on the safety of amphetamine stimulants for ADHD treatment during breastfeeding. Most data on the safety of these medications are from recreational abuse of methamphetamine. This study followed children (N = 13) exposed to amphetamine stimulants during breastfeeding. Assessments by Pediatric Quality of Life and Denver Developmental Scale evaluated neurodevelopment and outcomes. Study results showed normal neurodevelopment with no significant adverse effects. Findings suggest amphetamines are likely compatible with breastfeeding; however larger studies are needed.

Original language	English
Article number	116047
Journal	Psychiatry Research
Volume	339
DOIs	https://doi.org/10.1016/j.psychres.2024.116047
State	Published - Sep 2024

Keywords

Amphetamines
Breastfeeding
Neurodevelopment

Access to Document

10.1016/j.psychres.2024.116047

Cite this

@article{39356eb7ea414a39bfdce25a52f7207e,

title = "Amphetamine use for attention deficit hyperactive disorder during breastfeeding and children's neurodevelopmental outcomes: A pilot study",

abstract = "Attention deficit hyperactive disorder (ADHD) medication use rises among women of childbearing age and during pregnancy. Little is known on the safety of amphetamine stimulants for ADHD treatment during breastfeeding. Most data on the safety of these medications are from recreational abuse of methamphetamine. This study followed children (N = 13) exposed to amphetamine stimulants during breastfeeding. Assessments by Pediatric Quality of Life and Denver Developmental Scale evaluated neurodevelopment and outcomes. Study results showed normal neurodevelopment with no significant adverse effects. Findings suggest amphetamines are likely compatible with breastfeeding; however larger studies are needed.",

keywords = "Amphetamines, Breastfeeding, Neurodevelopment",

author = "{Benassayag Kaduri}, Nofar and Ariela Hazan and Tal De-Haan and Elkana Kohn and Matitiahu Berkovitch and Maya Berlin",

note = "Publisher Copyright: {\textcopyright} 2024 Elsevier B.V.",

year = "2024",

month = sep,

doi = "10.1016/j.psychres.2024.116047",

language = "אנגלית",

volume = "339",

journal = "Psychiatry Research",

issn = "0165-1781",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Amphetamine use for attention deficit hyperactive disorder during breastfeeding and children's neurodevelopmental outcomes

T2 - A pilot study

AU - Benassayag Kaduri, Nofar

AU - Hazan, Ariela

AU - De-Haan, Tal

AU - Kohn, Elkana

AU - Berkovitch, Matitiahu

AU - Berlin, Maya

PY - 2024/9

Y1 - 2024/9

N2 - Attention deficit hyperactive disorder (ADHD) medication use rises among women of childbearing age and during pregnancy. Little is known on the safety of amphetamine stimulants for ADHD treatment during breastfeeding. Most data on the safety of these medications are from recreational abuse of methamphetamine. This study followed children (N = 13) exposed to amphetamine stimulants during breastfeeding. Assessments by Pediatric Quality of Life and Denver Developmental Scale evaluated neurodevelopment and outcomes. Study results showed normal neurodevelopment with no significant adverse effects. Findings suggest amphetamines are likely compatible with breastfeeding; however larger studies are needed.

AB - Attention deficit hyperactive disorder (ADHD) medication use rises among women of childbearing age and during pregnancy. Little is known on the safety of amphetamine stimulants for ADHD treatment during breastfeeding. Most data on the safety of these medications are from recreational abuse of methamphetamine. This study followed children (N = 13) exposed to amphetamine stimulants during breastfeeding. Assessments by Pediatric Quality of Life and Denver Developmental Scale evaluated neurodevelopment and outcomes. Study results showed normal neurodevelopment with no significant adverse effects. Findings suggest amphetamines are likely compatible with breastfeeding; however larger studies are needed.

KW - Amphetamines

KW - Breastfeeding

KW - Neurodevelopment

UR - http://www.scopus.com/inward/record.url?scp=85196477986&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2024.116047

DO - 10.1016/j.psychres.2024.116047

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:85196477986

SN - 0165-1781

VL - 339

JO - Psychiatry Research

JF - Psychiatry Research

M1 - 116047

ER -

Amphetamine use for attention deficit hyperactive disorder during breastfeeding and children's neurodevelopmental outcomes: A pilot study

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this